Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP946590.RABP9FkKi4cYjZJ8M7ggCy56cMuMIRYwCKQR-gKS4FQmY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP946590.RABP9FkKi4cYjZJ8M7ggCy56cMuMIRYwCKQR-gKS4FQmY130_assertion type Assertion NP946590.RABP9FkKi4cYjZJ8M7ggCy56cMuMIRYwCKQR-gKS4FQmY130_head.
- NP946590.RABP9FkKi4cYjZJ8M7ggCy56cMuMIRYwCKQR-gKS4FQmY130_assertion wasGeneratedBy ECO_0000203 NP946590.RABP9FkKi4cYjZJ8M7ggCy56cMuMIRYwCKQR-gKS4FQmY130_provenance.
- NP946590.RABP9FkKi4cYjZJ8M7ggCy56cMuMIRYwCKQR-gKS4FQmY130_assertion wasDerivedFrom befree-20150227 NP946590.RABP9FkKi4cYjZJ8M7ggCy56cMuMIRYwCKQR-gKS4FQmY130_provenance.
- NP946590.RABP9FkKi4cYjZJ8M7ggCy56cMuMIRYwCKQR-gKS4FQmY130_assertion SIO_000772 21596848 NP946590.RABP9FkKi4cYjZJ8M7ggCy56cMuMIRYwCKQR-gKS4FQmY130_provenance.
- NP946590.RABP9FkKi4cYjZJ8M7ggCy56cMuMIRYwCKQR-gKS4FQmY130_assertion evidence source_evidence_literature NP946590.RABP9FkKi4cYjZJ8M7ggCy56cMuMIRYwCKQR-gKS4FQmY130_provenance.
- NP946590.RABP9FkKi4cYjZJ8M7ggCy56cMuMIRYwCKQR-gKS4FQmY130_assertion description "[Univariable survival analysis shows that (1) patients with FLT3(ITD) mutations have inferior overall survival (OS) and event-free survival (EFS), whereas CEBPA(DM) and NPM1 mutations indicate favorable OS and EFS in intermediate-risk AML, and (2) high transcript levels of BAALC, CD34, MN1, EVl1, and ERG predict inferior OS and EFS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946590.RABP9FkKi4cYjZJ8M7ggCy56cMuMIRYwCKQR-gKS4FQmY130_provenance.